CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	382K 335K 309K 288K 543K 36.14M 552K 3.7M 1.44M 17.83M 1.44M 1.4M 62.12M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 472K 435K 406K 765K 50.93M 779K 5.22M 2.03M 25.13M 2.02M 1.98M 87.56M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

21-09-09	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
21-09-03	CardioGenics Holdings Inc. Announces License Agreement	CI
15-11-01	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
15-10-04	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
15-01-12	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
13-09-27	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
13-08-21	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
13-06-05	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
13-06-03	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
13-05-31	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
13-02-28	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
13-02-26	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
12-04-17	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

21-09-28	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
21-09-09	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
21-09-03	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
15-11-04	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
15-10-05	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	2009-10-26
James A. Essex DFI	Director of Finance/CFO	78	2010-06-15
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Julian Neil Tabatznik CHM	Chairman	76	2010-06-15
Yahia A. Gawad BRD	Director/Board Member	68	2011-04-05
Linda J. Sterling BRD	Director/Board Member	65	2010-06-15

CardioGenics Holdings Inc Stock Other OTC

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Latest news : CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	-35.19%	+110.24%	-	-	142
GUARDANT HEALTH, INC.	-2.41%	+14.68%	+188.30%	+319.08%	19.89B
BIOMÉRIEUX	+0.58%	+1.39%	-41.09%	-26.16%	9.26B
LANTHEUS HOLDINGS, INC.	+1.24%	+4.63%	+35.52%	+32.20%	7.22B
CARIS LIFE SCIENCES, INC.	-2.73%	+1.25%	-33.31%	-	5.04B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-2.33%	-1.62%	-25.95%	-28.81%	4.86B
10X GENOMICS, INC.	+3.20%	+20.30%	+231.09%	-31.34%	4.87B
DIASORIN S.P.A.	+1.59%	+3.64%	-24.83%	-26.39%	4.1B
ANDON HEALTH CO., LTD.	+5.76%	+2.45%	+94.02%	+100.74%	4.35B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.94%	-6.08%	-22.61%	-43.90%	2.44B
Average	-3.31%	+5.66%	+44.57%	+36.93%	6.89B
Weighted average by Cap.	-0.30%	+7.97%	+75.85%	+109.98%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.35M -2.17M -2.02M -3.81M -253M -3.87M -25.97M -10.08M -125M -10.07M -9.84M -436M	-1.92M -1.68M -1.55M -1.44M -2.72M -181M -2.77M -18.57M -7.21M -89.41M -7.2M -7.04M -311M
Net Debt	132K 116K 107K 99.67K 188K 12.5M 191K 1.28M 498K 6.17M 497K 486K 21.49M	157K 137K 126K 118K 222K 14.8M 226K 1.52M 589K 7.3M 588K 575K 25.44M